Clinical trial
Atazanavir for HIV Infected Individuals: An Early Access Program
NCT00046345 · Bristol-Myers Squibb, Industry · No longer available
Key facts
| NCT number | NCT00046345 |
|---|---|
| Title | Atazanavir for HIV Infected Individuals: An Early Access Program |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | No longer available |
| Study type | Expanded Access |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir (BMS-232632) |
| Start date | May 1, 2002 |
| Completion | Jul 1, 2003 |
| First posted | Sep 30, 2002 |
| Last update posted | Apr 14, 2011 |
| Countries | Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: